Trial Oversight Spotlight #13: Kalyan Obalampalli
In this episode:
Tom Lazenby and Kalyan Obalampalli discuss the challenges and opportunities in vendor management within clinical trials. Kalyan shares his journey in founding Clin.ai, a platform designed to streamline vendor selection and management processes. They explore the importance of networking, the lessons learned from previous experiences, and the critical role of financial oversight in clinical trials. The discussion also highlights the unique challenges faced by smaller biotech companies and offers practical tips for improving vendor selection processes.
Key points:
- Identifying problems through conversations is crucial
- Vendor selection is a complex process with many challenges
- Poor vendor choices can lead to significant financial losses
- Smaller companies face unique challenges in vendor management
- Utilising technology can streamline vendor selection
- The importance of financial oversight in clinical trials
Time stamps:
- – Intro
- – The Birth of Clin.AI
- – Identifying Vendor Management Challenges
- – The Importance of Vendor Selection
- – Consequences of Poor Vendor Choices
- – Vendor Selection Challenges
- – The Impact of Budget on Small Biotechs
- – Quality by Design in Clinical Trials
- – Actionable Tips for Better Vendor Selection
Guest Bio
Kalyan Obalampalli
Founder and President of Clin.AI
Kalyan Obalampalli is a technology innovator with over 20 years of leadership experience in Clinical Operations and Outsourcing at major pharma and biotechs. Combining his expertise in clinical operations and software development, he has created user-friendly solutions, including a platform for clinical trial vendor selection and management.
With advisory experience in Silicon Valley start-ups, Kalyan brings a unique perspective to transforming Clinical Development Operations through technology.
Host Bio
Tom is running the Trial Oversight Spotlight Interview Series where he meets with a variety of colleagues working in clinical research. They discuss a selection of the most important topics and decisions that are currently being navigated by all types of organisations delivering research.
Tom has spent over a decade in Clinical Trials Operations and Quality Assurance and has experienced the impact that suboptimal vendor oversight and vendor non-compliance can have on the quality of clinical trials. Mayet is the solution to fix this.